The present invention relates to an implantable medical apparatus and a method for detecting diastolic heart failure, DHF, and a pacemaker comprising said apparatus.
There is a growing recognition that congestive heart failure caused by a predominant abnormality in the diastolic function, i.e. diastolic heart failure, DHF, is both common and causes significant morbidity and mortality. Therefore early detection of DHF is important. Patients do not, however, seem to have symptoms at an early stage. In addition it has been hard to separate diastolic and systolic heart failure, and they may also exist simultaneously.
DHF is characterized by a slowing down of the recoil effect during early diastole, i.e. during the isovolumic ventricular relaxation and the rapid left ventricular filling phase, before the atrial contraction. This has been observed by measuring the velocity of the mitral annulus. According to an article by Margaret M. Redfield et. al., “Burden of Systolic and Diastolic Ventricular Dysfunction in the Community, JAMA, Vol. 289, No. 2, p. 194-202, Jan. 8, 2003, the velocity of the mitral annulus motion reflects the state of DHF. The article shows that the velocity of the mitral annulus motion decreases when the diastolic function gets more deteriorated.
However, the measurement of heart tissue has already been used for other purposes. For example, U.S. Pat. No. 5,480,412 A discloses a processing system and method for deriving an improved hemodynamic indicator from cardiac wall acceleration signals. The cardiac wall acceleration signals are provided by a cardiac wall sensor that responds to cardiac mechanical activity. The cardiac wall acceleration signals are integrated over time to derive cardiac wall velocity signals, which are further integrated over time to derive cardiac wall displacement signals. The cardiac wall displacement signals correlate to known hemodynamic indicators. An implantable cardiac stimulating device using cardiac wall displacement signals to detect and discriminate cardiac arrhythmias is also described. Further, U.S. Pat. No. 5,628,777 A discloses an implantable lead comprising an accelerometer-based cardiac wall motion sensor. Said sensor transduces accelerations of cardiac tissue to provide electrical signals indicative of cardiac wall motion to an implantable cardiac stimulation device. Said device uses said electrical signals to detect and discriminate among potentially malignant cardiac arrhythmias. Furthermore, U.S. Pat. No. 6,009,349 A discloses a processing system for an implantable cardiac device, said device having cardiac wall accelerator sensors for providing a cardiac wall accelerator signal as a function of cardiac wall contractile motion, the sensors being positioned in the right atrium and right ventricle of a patent's heart.
The object of the present invention is to utilize above mentioned knowledge to propose a technique for detecting DHF, preferably at an early stage when the patient still does not seem to have any symptoms, based on the movement of the mitral annulus.
The above-mentioned object is achieved by an apparatus, a pacemaker, and a method of the kind mentioned in the introductory portion of the description and having the characterizing features of claims 1, 16 and 17, respectively. It has been shown that the movement of the valve plane of the heart is comparable to the movement of the mitral annulus, so by the apparatus, pacemaker, and method of the present invention is an efficient technique for detecting DHF provided, also for detecting DHF at an early stage when the patient still does not seem to have any symptoms.
According to advantageous embodiments of the apparatus according to the present invention, the analysing means comprise a comparison means for comparing the measured movement of the valve plane with predetermined reference values, and the measuring means is arranged to measure the movement of the valve plane during early diastole, before the atrial contraction.
According to another advantageous embodiment of the apparatus according to the present invention, the apparatus comprises first detection means for detecting the T-wave, and the measuring means is arranged to measure the movement of the valve plane in the vicinity of the T-wave.
According to a further advantageous embodiment of the apparatus according to the present invention, the apparatus comprises second detection means for detecting the QRS complex, and the measuring means is arranged to measure the movement of the valve plane during a time window starting just after the QRS complex and ending before the atrial contraction.
According to an advantageous embodiment of the apparatus according to the present invention, the apparatus comprises activity measuring means for measuring the condition of the patient, and the measuring means is arranged to measure the movement of the valve plane when the activity measuring means indicates resting conditions of the patient.
According to a further advantageous embodiment of the apparatus according to the present invention, the measuring means is arranged to measure movement of the valve plane by measuring the velocity or the acceleration of the valve plane.
According to other advantageous embodiments of the apparatus according to the present invention, the measuring means comprises an accelerometer arranged to be placed on or close to the valve plane, and the apparatus comprises calculating means for calculating the velocity of the valve plane by summing-up or integrating the measured acceleration values.
According to still other advantageous embodiments of the apparatus according to the present invention, the measuring means is arranged to measure the pressure from the inner walls of the coronary sinus, the great cardiac vein or a coronary vein, said pressure correlating with the movement of the valve plane, and the measuring means arranged to measure said pressure comprises a pressure sensor with a circumferential sensitivity arranged to be placed in the coronary sinus, the great cardiac vein or in a coronary vein.
According to yet other advantageous embodiments of the apparatus according to the present invention, the analysing means are arranged to find the peak value from measured values from one heart interval, the apparatus comprises an averaging means for forming an average value of peak values from measured values from several heart intervals, and the apparatus comprises storing means for storing measured values together with the time of occurrence, for later analysis.
According to advantageous embodiments of the method according to the present invention, the measured movement of the valve plane is compared with predetermined reference values, and the movement of the valve plane is measured during early diastole, before the atrial contraction.
According to a further advantageous embodiment of the method according to the present invention, the T-wave is detected, and the movement of the valve plane is measured in the vicinity of the T-wave.
According to another advantageous embodiment of the method according to the present invention, the QRS complex is detected, and the movement of the valve plane is measured during a time window starting just after the QRS complex and ending before the atrial contraction.
According to other advantageous embodiments of the method according to the present invention, the condition of the patient is measured, and the movement of the valve plane is measured, by measuring the velocity or the acceleration of the valve plane, during resting conditions of the patient, and if the acceleration of the valve plane is measured, the velocity of the valve plane is calculated from the acceleration by summing-up or integrating the measured acceleration values, e.g.
According to yet another advantageous embodiment of the method according to the present invention, the pressure is measured from the inner walls of the coronary sinus, the great cardiac vein or a coronary vein, said pressure correlating with the movement of the valve plane.
According to still other advantageous embodiments of the method according to the present invention, the method comprises the special measures of finding the peak value from measured values from one heart interval, forming an average value of peak values from measured values from several heart intervals, and storing measured values together with the time of occurrence, for later analysis.
The present invention will now be described, for exemplary purposes, in more detail by way of embodiments and with reference to the enclosed drawings, in which:
In the diagrams for Doppler Tissue Imaging of Mitral Annular Motion of
The DHF is a slow process. Therefore, the points in time for measuring the acceleration of the valve plane 6 is preferably applied to occasions when the patient is only making small movements and the signal interference is low, e.g. during sleep. In order to identify such moments the pacemaker comprises an activity sensor 10 connected to an activity measuring unit 11 for measuring the condition of the patient, which unit 11 in turn is connected to the microprocessor and supporting circuits 8. The microprocessor and supporting circuits 8 provide a timer 12 for starting the process of measuring the movement of the valve plane 6, the function of which is described in connection to
The diastolic phase of interest is during the isovolumic ventricular relaxation and the rapid left ventricular filling phase, before the atrial contraction, thus the microprocessor and supporting circuits 8 provide detection means 13 for detecting the QRS complex from the signals captured by the electrode 2. The occurrence of peak velocity of the valve plane 6 takes place only a small varying time delay after the QRS complex. The microprocessor and supporting circuits 8 are arranged to lay down a time window, with a width of about 100 ms, enough to cover the valve plane motion during the relaxation phase, which starts just after the QRS complex and ends before the atrial contraction, and the accelerometer 5 is arranged to measure the acceleration of the valve plane 6 during said time window. The microprocessor and supporting circuits 8 provide calculating means 14 for calculating the velocity of the valve plane 6 by summing-up or integrating the measured acceleration values during said time window. The microprocessor and supporting circuits 8 also provide analysing means 15 for finding the peak value from measured values from one heart interval. Further, the microprocessor and supporting circuits 8 provide storing means 16 for storing measured values together with the time of occurrence, for later analysis. Thus, the development of valve plane movement values over time can be obtained. Additionally, the microprocessor and supporting circuits 8 provide averaging means 17 for forming an average value of peak values from measured values from several heart intervals. The analysing means 15 are arranged to analyse the measurement of the movement of the valve plane 6, and comprise a determining means 18 for determining a slowdown of the movement of the valve plane 6 for indicating a DHF state of the heart 4 of a patient from the determined slowdown. Further, the analysing means 15 comprise a comparison means 19 for comparing the measured movement of the valve plane 6 with pre-determined reference values. The comparison with reference values supports the indication of a DHF state. Finally, the microprocessor and supporting circuits 8 provide control means 20 for optimising pacing therapy depending on the result of the analysis of the measured movement of the valve plane 6.
If the implantation of the pacemaker occurs at a point in time when no essential DHF is at hand, the peak velocity obtained will be the basis for evaluating the degree of DHF. The pacemaker can also measure absolute peak velocity if the processed accelerometer signal is calibrated. This can be done by comparing the peak velocity found by the pacemaker with the peak velocity found by ultrasonic equipment suitable for such measurements. It is enough to measure and calibrate one peak velocity, since the accelerometer will show zero signal at zero velocity.
When the QRS complex is detected, a delay is laid out, at 39, at the end of which the time window is opened, and the storing of accelerator signal samples during the time window starts, at 40. The acceleration samples from the accelerator are integrated or summed up, at 41, to obtain the velocity, and the peak velocity is found during said time window, at 42, and added to a sum of peak velocities, at 43. The steps 38 to 44 are repeated for n heart intervals, and when peak velocities from n heart intervals have been collected, at 45, and added to the sum of peak velocities, at 43, an average value of the peak velocities from the n heart intervals is formed, at 46, by dividing the sum of peak velocities by the number of heart intervals, n. The number n may be in the order of 10, but it is not a critical number. The average value of the peak velocities is stored together with the time of occurrence, at 47, for analysis in order to detect a DHF state of the heart of a patient. Said analysis comprises the step of determining a slowdown of the movement of the valve plane for indicating a DHF state of the heart of a patient from the determined slowdown.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/SE04/01247 | 8/31/2004 | WO | 00 | 1/29/2007 |